# Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma

> **NCT07030842** · — · COMPLETED · sponsor: **Tongji Hospital** · enrollment: 579 (actual)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **PROCEDURE:** liver resection

## Key facts

- **NCT ID:** NCT07030842
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-25
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 579 (ACTUAL)
- **Last updated:** 2025-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07030842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07030842, "Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07030842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*